Pharmacokinetics of Polymyxin B in an Infant With Multidrug-resistant Klebsiella pneumoniae Bacteremia
The Pediatric Infectious Disease Journal, ISSN: 0891-3668, Vol: 30, Issue: 6, Page: 537-539
2011
- 2Citations
- 16Captures
Metric Options: Counts1 Year3 YearSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Metrics Details
- Citations2
- Citation Indexes2
- CrossRef2
- Captures16
- Readers16
- 16
Article Description
We report our experience with a 9-month-old infant treated with intravenous polymyxin B for multidrug-resistant Klebsiella pneumoniae bacteremia. Serial blood samples were obtained at steady state and serum drug concentrations were determined using a validated liquid chromatography-mass spectrometry method. The elimination half-lives of polymyxin B1 and isoleucine-polymyxin B1 were found to be 3.1 and 4.7 hours, respectively.
Bibliographic Details
http://www.sciencedirect.com/science/article/pii/S0891366811601492; http://dx.doi.org/10.1097/inf.0b013e318207a7c1; http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=79958004476&origin=inward; http://www.ncbi.nlm.nih.gov/pubmed/21164382; http://Insights.ovid.com/crossref?an=00006454-201106000-00025; https://journals.lww.com/00006454-201106000-00025; https://dx.doi.org/10.1097/inf.0b013e318207a7c1; https://journals.lww.com/pidj/Fulltext/2011/06000/Pharmacokinetics_of_Polymyxin_B_in_an_Infant_With.25.aspx
Ovid Technologies (Wolters Kluwer Health)
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know